1. Health care in Russia:
the nearest future great challenges
Bachinskaya Elena,
Medical manager,
Janssen, Russia

2. Health care in Russia: general assumptions 2013-2014
2013
• Flat investments in out-patients drug provision programs
• Growth of reimbursement market is driven by hospital segment
• Prioritization for local drugs development and production
• Treatment standards implementation
• One-channel financing
• Regions are responsible for medico-economical standards creation and
execution
2014
• Decentralization of essential drug programs execution to regional level
• Regional budget calculation based on per capita spending
• National Drug Insurance: pilot regions 2014, implementation in 2015-2016
Goals for Russian Pharma 2020:
local R&D and production +
new federal medical insurance system

3. 4 main innovations will ensure
competitiveness of new health care system
 Specification of standards of medical care and related measures to
improve the economic efficiency
 Transition to a single channel financing through the Federal mandatory
health insurance fund
 Expansion of financing of a limited number of medical institutions and the
freedom of choice of medical institutions for patients
 Strengthening of regional autonomy in making decisions on the issues of
health and complication access to market for new players

4. Health care financing will shift to
the Unified national funding organization
Source of expenses in health
care, billions $
Government National insurance Personal expenses
budget
Ascher J et al. Russian health care evolution.
McKinsey Bulletin, Moscow, 2012

5. How to be prepared to the reforms:
my role in medium term view
 Enhance scientific and clinical competitive advantages for products and company to
customers expectations
 Create new health care professionals management approach based on systematic
development and maintenance of customer relationships for increasing their satisfaction
and loyalty (from customer to integrated partner)
 Establish professional Medical affairs support as a important competence for pharma
company
 Rebuild medical information management
 Pharma company portfolio management for budget segments access: shift from central
to regional execution
New working approach
with external and internal customers